Your browser doesn't support javascript.
loading
In Vitro Activities of Ceftazidime-Avibactam, Aztreonam-Avibactam, and a Panel of Older and Contemporary Antimicrobial Agents against Carbapenemase-Producing Gram-Negative Bacilli.
Vasoo, Shawn; Cunningham, Scott A; Cole, Nicolynn C; Kohner, Peggy C; Menon, Sanjay R; Krause, Kevin M; Harris, Kelly A; De, Partha P; Koh, Tse Hsien; Patel, Robin.
Afiliação
  • Vasoo S; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA Department of Infectious Diseases, Institute of Infectious Diseases and Epidemiol
  • Cunningham SA; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Cole NC; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kohner PC; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA.
  • Menon SR; Clinical Microbiology, Department of Laboratory Medicine, Tan Tock Seng Hospital Singapore.
  • Krause KM; Forest Research Institute, Inc., Jersey City, New Jersey, USA.
  • Harris KA; Forest Research Institute, Inc., Jersey City, New Jersey, USA.
  • De PP; Clinical Microbiology, Department of Laboratory Medicine, Tan Tock Seng Hospital Singapore.
  • Koh TH; Department of Pathology, Singapore General Hospital, Singapore.
  • Patel R; Division of Clinical Microbiology, Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, Minnesota, USA Division of Infectious Diseases, Department of Medicine, Mayo Clinic, Rochester, Minnesota, USA patel.robin@mayo.edu.
Antimicrob Agents Chemother ; 59(12): 7842-6, 2015 Dec.
Article em En | MEDLINE | ID: mdl-26392487
ABSTRACT
Among 177 carbapenemase-producing Gram-negative bacilli (108 KPC, 32 NDM, 11 IMP, 8 OXA-48, 4 OXA-181, 2 OXA-232, 5 IMI, 4 VIM, and 3 SME producers), aztreonam-avibactam was active against all isolates except two NDM producers with elevated MICs of 8/4 and 16/4 mg/liter; ceftazidime-avibactam was active against all KPC-, IMI-, SME-, and most OXA-48 group-producing isolates (93%) but not metallo-ß-lactamase producers. Among older and contemporary antimicrobials, the most active were colistin, tigecycline, and fosfomycin, with overall susceptibilities of 88%, 79%, and 78%, respectively.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Aztreonam / Ceftazidima / Enterobacteriaceae / Compostos Azabicíclicos / Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteínas de Bactérias / Beta-Lactamases / Aztreonam / Ceftazidima / Enterobacteriaceae / Compostos Azabicíclicos / Antibacterianos Idioma: En Ano de publicação: 2015 Tipo de documento: Article